COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration
Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.
The Netherlands recently developed a national structure to ensure systematic distribution of SARS-CoV-2 testing and supplies for significantly expanding COVID-19 testing capacity. In the US, wide use of these antigen tests presents two key opportunities for clinical laboratories.
A particular grouping of several blood tests is needed to utilize this disease severity score. The predictive value of such clinical laboratory testing as a risk assessment model could drive an increase in seven key lab tests.
Three types of clinical laboratory testing support were stipulated with first FDA approval of antiviral drug for COVID-19 treatment.
Some 122 clinical laboratories reveal how supply shortages extend beyond COVID-19 testing supplies.
Possible new source of partnership for clinical laboratories for COVID-19 testing, especially in established networks.
Cost points and challenges emerging from new airport COVID-19 testing models.
The Netherlands recently developed a national structure to ensure systematic distribution of SARS-CoV-2 testing and supplies for significantly expanding COVID-19 testing capacity. In the US, wide use of these antigen tests presents two key opportunities for clinical laboratories.
A particular grouping of several blood tests is needed to utilize this disease severity score. The predictive value of such clinical laboratory testing as a risk assessment model could drive an increase in seven key lab tests.
Three types of clinical laboratory testing support were stipulated with first FDA approval of antiviral drug for COVID-19 treatment.
Some 122 clinical laboratories reveal how supply shortages extend beyond COVID-19 testing supplies.
Possible new source of partnership for clinical laboratories for COVID-19 testing, especially in established networks.
Cost points and challenges emerging from new airport COVID-19 testing models.
